Newer Methods for Noninvasive Assessment of Myocardial Perfusion Cardiac Magnetic Resonance or Cardiac Computed Tomography? by Nagel, Eike et al.
NN
o
C
E
L
S
N
N
m
s
a
E
c
(
e
c
i
i
H
p
q
t
s
m
o
c
G
p
s
i
r
v
M
F
J A C C : C A R D I O V A S C U L A R I M A G I N G V O L . 2 , N O . 5 , 2 0 0 9
© 2 0 0 9 B Y T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N D A T I O N I S S N 1 9 3 6 - 8 7 8 X / 0 9 / $ 3 6 . 0 0
P U B L I S H E D B Y E L S E V I E R I N C . D O I : 1 0 . 1 0 1 6 / j . j c m g . 2 0 0 9 . 0 2 . 0 0 7E W S A N D V I E W S
ewer Methods for Noninvasive Assessment
f Myocardial Perfusion
ardiac Magnetic Resonance or Cardiac Computed Tomography?
ike Nagel, MD, PHD, João A. C. Lima, MD, Richard T. George, MD
ondon, United Kingdom; and Baltimore, Maryland
ection Editor: Christopher M. Kramer, MD
U C L E A R S C I N T I G R A P H Y I S T H E M O S T C O M M O N L Y U S E D T E C H -
I Q U E for assessingmyocardial perfusion in cardiovascularmedicine in 2009. However, the pendulum
ay swing toward newer imaging modalities over the next several years. Techniques with improved
patial resolution aswell as speedof acquisitionmaybeusedwith increasing frequency.Onequestion thatrises is, which technique will that be?
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cike Nagel, MD, PhD, makes an excellent
ase for cardiac magnetic resonance
CMR), discussing its high accuracy, the
merging data on prognosis, the powerful
ombination with late gadolinium-enhanced
maging of infarction, and relative safety,
ncluding freedom from radiation exposure.
e readily points out the limitations at
resent for CMR which include the re-
uirement for advanced training to be able
o read through artifacts and the need for
implification of acquisition of the data on
any of the modern platforms. The future
f CMR lies in full quantification of myo-
ardial blood flow.
João A. C. Lima, MD, and Richard T.
eorge, MD, make the case for cardiac com-
uted tomography (CT). The greatest
trength of cardiac CT lies in its anatomic
maging of the coronaries with high spatial
esolution and excellent negative predictive
alue. Combining perfusion data in studiest
anuscript received January 15, 2009; revised manuscript received
ebruary 23, 2009, accepted February 27, 2009.ith positive angiographic findings could cut
own on the false-positive rate and improve
verall accuracy in the combined examina-
ion. In addition, there are some patients
ith microvascular disease who may manifest
bnormal regional perfusion despite absent
picardial stenoses. Limitations of the current
echnology include the high radiation dose
ecessary to do stress and rest studies. This
roblem may be overcome in the future with
rospective gating and the advent of 256-
nd 320-detector row scanners.
For those cardiovascular imagers unsure of
here the future may lie, please read on.
MR Perfusion Imaging:
he First-Line Imaging
echnique?
ike Nagel, MD, PHD
erfusion is the answer. It is without much
ebate today that the pure visualization of
he coronary artery lumen is insufficient for
linical decision making. The use of frac-
ional flow reserve has been shown to be a
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657uperior approach with better out-
omes and reduced costs (1). Simi-
arly, multiple studies have demon-
trated that the absence of ischemia
s a good predictor of event-free sur-
ival, and that the severity of ischemia
s closely correlated to the occurrence
f events (2,3). It seems to be impor-
ant, however, to leave the concept of
erely determining the presence or
bsence of ischemia and, rather, to
ove forward to determining the se-
erity of myocardial ischemia. Clearly,
ny test to be used several times in
ife (for example, to assess recurring
ymptoms after treatment or remain-
ng ischemia after initiation of ther-
py) or used to exclude disease to
etermine prognosis must be as mini-
ally harmful as possible.
MR perfusion is highly accurate. CMR
erfusion imaging has now been
idely validated and found to be
ighly accurate. In animal experi-
ents, it has been shown to correlate
ell with microspheres and to be
uperior to single-positron emission
omputed tomography (SPECT),
ost likely because of the higher
patial resolution of CMR perfusion
maging (4). Similarly, it has been
alidated against coronary flow re-
erve with a good correlation (with an
value of approximately 0.86). Com-
arison with fractional flow reserve
esulted in a less favorable correla-
ion. Classification of patients into
ormal or abnormal fractional flow
eserve using CMR perfusion resulted
n a sensitivity of approximately 90%
ith a specificity of approximately
0% in 2 studies, with a lower speci-
city (56%) in 1. Some differences to
ractional flow reserve are to be ex-
ected, because coronary flow reserve
s reduced in microvascular disease
imilar to CMR or cardiac CT per-
usion imaging, whereas fractional
ow reserve remains normal in these
atients. The importance of these
ndings needs to be addressed in
uture studies. In several multicenter itudies, the accuracy of CMR perfu-
ion to determine coronary artery ste-
oses has been evaluated. The largest
multicenter multivendor trials are
he IMPACT (Integrilin to Mini-
ize Platelet Aggregation and Pre-
ent Coronary Thrombosis) (5) and
MPACT II studies. In these trials,
he superiority of CMR perfusion
ver SPECT for the prediction of an
picardial coronary stenosis was
hown. Owing to the differences of
he parameters measured (luminal
tenosis versus myocardial ischemia),
o 100% correlation between CMR
erfusion imaging and the presence of
luminal stenosis can be expected.
rognostic value of CMR perfusion. To
ptimally guide therapy and decide
hether to proceed to revasculariza-
ion, it is more important to prove or
xclude ischemia and predict the occur-
ence of events, rather than merely
rove the presence of a luminal steno-
is. Several studies have shown the high
redictive value of CMR perfusion im-
ging for prognosis, both in the acute
etting and for the chronic stable pa-
ient. A normal perfusion CMR test
redicts an event rate (defined as car-
iac death or nonfatal myocardial in-
arction) of 0.7% in the first and second
ear after a normal perfusion test and
.8% per year over a 3-year period after
he test (6). Interestingly, the likeli-
ood for event-free survival was iden-
ical to that in SPECT studies, whereas
ore events occurred in the positive
rm of the study, demonstrating a
igher prevalence of disease in the
MR study compared to previous
PECT studies. In the acute setting, a
egative perfusion CMR showed 100%
ensitivity and a positive perfusion
MR showed 91% specificity to pre-
ict future adverse cardiac events (7).
afety. CMR has an excellent safety
rofile. If the contraindications are fol-
owed, no harm from the magnetic field
as been demonstrated. The major
oncerns are claustrophobia, occurring
n approximately 2% of the patients, tnd side effects of the gadolinium-
ontaining contrast agent. Whereas
hese agents have no effects on kidney
unction and only very rarely lead to
mild) allergic reactions, the induction
f nephrogenic systemic fibrosis has
een recently discussed. Fortunately,
he use of low contrast agent doses, as
outinely used for CMR perfusion im-
ging, has not been shown to have
aused a single case of nephrogenic
ystemic fibrosis so far.
echnique limitations. CMR is a low-
nergy technique and, therefore, has no
ignificant side effects as related to ra-
iation. Conversely, however, espe-
ially in combination with high-
esolution imaging (3  3 mm in
oday’s standard techniques), images
re noisier and have more artefacts than
o perfusion images from high-energy
echniques (CT, SPECT, positron
mission tomography) or other mag-
etic resonance images (for example,
ate gadolinium enhancement or cine
mages). Consequently, reading the im-
ges is not always straightforward and
equires some experience. Fortunately,
t is possible to decide on the presence
nd type of artifact based on the im-
ges, and thus decide early in the anal-
sis process whether to refrain from
nalysis (in rare cases) or to exclude
ome segments. In approximately 85%
f cases no significant artifacts are
ound.
A second potential limitation is the
apid progress of the technique, limit-
ng standardization and confusing
ome (potential) users. This rapid
rogress is related to the urge of re-
earchers to minimize artefacts, allow
or full quantification, and come up
ith even higher spatial resolution im-
ging (for example, 1 mm  1 mm).
ven though that introduces a multi-
ude of techniques, there are several
asic techniques available that are im-
lemented on most magnetic resonance
canners in use today and have been
dequately validated in multicenter set-
ings.
s
n
w
r
“
c
e
P
o
b
s
d
d
f
p
(
a
o
c
i
F
m
t
t
w
e
i
e
t
i
e
b
t
n
W
h
t
a
t
p
p
a
t
S
s
p
t
c
t
a
C
A
M
I
F
T
J
R
T
t
n
b
n
p
t
s
c
u
t
f
g
c
s
t
s
b
t
a
c
m
n
i
t
f
b
g
H
c
m
w
g
s
C
e
m
l
c
h
c
b
l
a
o
e
W
n
s
a
u
w
p
p
t
h
n
T
s
v
w
g
w
c
p
i
m
c
w
e
s
m
(
w
d
n
s
b
f
i
t
t
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 2 , N O . 5 , 2 0 0 9
M A Y 2 0 0 9 : 6 5 6 – 6 0
Nagel et al.
Perfusion: CMR or Cardiac CT
658Interestingly, most limitations ob-
erved with previous perfusion tech-
iques are less of a problem. Patients
ith multivessel disease can be accu-
ately identified, since the problem of
balanced ischemia” seems to be over-
ome by the ability to discriminate
ndocardial and epicardial perfusion.
atients who have had bypass surgery
r previous myocardial infarction can
e readily examined. Owing to the high
patial resolution, it is possible to ad-
ress complex perfusion patterns and
etect peri-infarct ischemia. Clearly,
or many patients, the combination of
erfusion imaging with scar imaging
late gadolinium enhancement) is valu-
ble, because the accurate visualization
f a necrotic area allows for good dis-
rimination of irreversible and revers-
ble damage.
uture. In the future, we will see 2
ajor developments. First, many cen-
ers will move toward full quantifica-
ion of myocardial blood flow. That
ill allow for not only determining the
ffect of therapy but also better address-
ng the severity, rather than only the
xtent, of disease. Second, the impor-
ance and presence of subendocardial
schemia and its differentiation from
picardial coronary artery disease will
e better understood. The impact of
hese findings on clinical medicine then
eeds to be addressed.
hy CMR? Clearly, a well-validated,
ighly accurate, rapid, noninvasive
echnique without the use of radiation
nd using a small dose of a well-
olerated contrast agent is the best ap-
roach to deliver good medicine to our
atients.
The higher complexity of CMR im-
ging in comparison with some other
echniques (for example, CT or
PECT) does not allow us to use these
impler techniques at a cost to the
atient (for example, applying radia-
ion), but should rather force us to
ontinue to learn and force the vendors
o simplify magnetic resonance imaging
s a whole. Combined Coronary
ngiography and
yocardial Perfusion
maging by CT: The
uture May Be Closer
han Anticipated
oão A. C. Lima, MD
ichard T. George, MD
he current management of symp-
omatic patients with suspected coro-
ary artery disease (CAD) frequently
egins with attempts to detect coro-
ary stenosis causing a myocardial
erfusion defect by using nuclear iso-
opic techniques. The identification of
uch lesions generally leads to invasive
oronary angiography for further doc-
mentation of vessel stenosis, ana-
omic characterization, and suitability
or catheter-based intervention or sur-
ery if clinically indicated. More re-
ently, the advent of CT angiography
uggests that the option of beginning
he workup of younger patients with
uspected CAD with an anatomic-
ased study, instead of a test designed
o look at myocardial perfusion, makes
lot of sense. Indeed, the possibility of
oupling anatomic and functional infor-
ation in 1 single test tailored to the
eeds of specific patients could have
mportant implications for the evalua-
ion of CAD clinically.
The notion that CT could provide in-
ormation on myocardial perfusion has
een documented in the past by investi-
ators using electron beam CT (8).
owever, the combination of a reliable
oronary angiogram with stress-induced
yocardial perfusion assessment had to
ait until spiral CT technology pro-
ressed sufficiently to enable the acqui-
ition of 64 slices simultaneously (9,10).
urrently, the greatest limitations to
T coronary angiography are the pres- unce of severely calcified coronary seg-
ents, stents, or other artifacts that
imit luminal visualization. Patients with
alcified arteries tend to be older and/or
ave advanced CAD. Their studies are
hallenging from a diagnostic viewpoint
ecause vulnerable plaques and stenotic
esions may be hidden underneath large
mounts of calcium accumulated in the
uter portions of atherosclerotic plaques
ncompassing 1 or more segments.
hile progress in multidetector tech-
ology has improved our ability to
tudy such patients, greater coverage
nd improved temporal resolution are
nlikely to eliminate the problem,
hich is in large part intrinsic to the
athogenesis of atherosclerosis, namely,
laques grow outwardly first and tend
o accumulate calcium as part of the
ealing process, therefore creating a
atural shield to X-ray penetration.
hat is a particular limitation to the
tudy of older persons, patients with ad-
anced CAD, and patients who under-
ent coronary artery bypass graft sur-
ery or multiple stent implantation, as
ell as patients with diseases such as
hronic renal failure that accelerate
laque calcification.
Initial subclinical studies document-
ng the possibility of translating these
ethods to humans indicate that the
ombination of coronary angiograms
ith measurements of relative differ-
nces in myocardial blood flow during
tress are feasible with current 64-slice
ultidetector computed tomography
MDCT) technology (9,11). Previous
ork using CMR to measure myocar-
ial perfusion suggests that most of the
eeded information is provided by the
tress images. However, differentiation
etween stress-induced perfusion de-
ects and myocardial scar such as old
nfarcts or myocardial fibrosis secondary
o previous myocardial damage or due
o other disease processes hampers the
se of stress studies only. Thus, baseline
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659tudies at rest are crucial for the full
mplementation of this technology. In
his regard, the main obstacle for its full
mplementation has been the magni-
ude of radiation that would be needed
or the acquisition of myocardial perfu-
ion information not only during stress,
ut also at rest using current 64-row
DCT technology with retrospective
ating.
Recent developments in MDCT
echnology that would allow for pro-
pective gating during 64-row MDCT
12), or for complete myocardial imag-
ng during 1 gantry rotation (13), have
reated the possibility of reducing radia-
ion exposure enough to enable the per-
ormance of combined angiography and
yocardial perfusion assessment at rest
nd during stress. It is feasible to per-
orm both studies with current tech-
iques and a total of 8 to 10 millisiev-
rts. Moreover, if the coronary
ngiogram provides the complete diag-
ostic picture, the cardiologist could
lect not to perform a perfusion study.
ased on current studies of patients
ith suspected coronary artery disease
14), we estimate that perfusion imag-
ng would be required in only 25% to
0% of cases, depending on the type of
opulation being studied. Such tech-
iques would be ideal for the assess-
ent of the patient with chest pain andistory of advanced disease, expected to e
myocardial perfusion single photon emission
computed tomography in patients with nor-ave calcified coronaries or previously
laced coronary stents. It is possible
hat the addition of perfusion informa-
ion to the angiographic study would
ncrease the test sensitivity to flow-lim-
ting lesions and facilitate the indication
or revascularization procedures even for
atients without extensively calcified ar-
eries or coronary stents, based on the
ombination of anatomic plus func-
ional information.
Moreover, recent attention to pa-
ients with chest pain but no obstruc-
ive epicardial CAD (microvascular
schemia) (15) has demonstrated that,
or a substantial proportion of these
atients, microvascular processes can
e identified by perfusion reserve
easurements in association with tra-
itional CAD risk factors such as hy-
ercholesterolemia, hypertension, smok-
ng, and diabetes mellitus (16). The
ossibility of quantifying epicardial
oronary plaque burden while also as-
essing microvascular disease during
aximal vasodilation by MDCT an-
iography would have profound im-
lications for the future evaluation of
ymptomatic persons at risk of devel-
ping complications of CAD. For
opulations with a majority of His-
anic, African-American, and Asian
ndividuals, one would expect that
hest pain due to microvascular dis-
ase secondary to diabetes and hyper- c
nostic value of cardiac magnetic resonanceension may be as prevalent as chest
ain caused by epicardial coronary ar-
ery obstruction. The possibility of
erforming a test that quickly differ-
ntiates between the 2 processes and
heir combination could be of great
alue clinically.
The advent of 320-row MDCT
echnology has allowed for the perfor-
ance of baseline angiographic and
tress perfusion studies at reasonable
evels of radiation (17). Considering
he fast pace of progression of
DCT technology, it is reasonable to
peculate that, indeed, the future may
e closer than previously anticipated.
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